| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-15 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-12 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-12 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.45 | 4e-11 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-10 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-08 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.27 | 2e-06 |